EP0034-#A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PEDIATRIC EPILEPSY SUBJECTS WITH PARTIAL-ONSET SEIZURES

Detalles del proyecto

EstadoFinalizado
Fecha de inicio/Fecha fin11/20/1311/30/16

Financiación

  • UCB Pharma (domestic): 10.531,00 US$